Oncology Central

ASCO18: MSI-H tumor patients more likely to have Lynch Syndrome, genomic study demonstrates

0
A genomic study of more than 15,000 tumor samples, led by researchers at Memorial Sloan Kettering Cancer Center (NY, USA), demonstrates that patients with tumors that have high microsatellite instability (MSI-H) are more likely to have Lynch syndrome.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.

Share:

Insights

Videos

News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.